CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 3,676.4	$ 1,132.3
Short-term investments (Note 6)	769.7	500.5
Accounts receivable, net of allowances of $12.6 and $8.2, respectively	716.0	771.5
Other receivables	95.5	56.6
Inventories (Note 2)	1,104.2	903.5
Prepaid expenses	114.9	128.8
Other current assets	231.0	224.9
Current assets of discontinued operations (Note 5)	20.0	317.6
Total current assets	6,727.7	4,035.7
Long-term investments (Note 6)	319.6	583.9
Property, plant, and equipment, net	1,675.7	1,591.0
Operating lease right-of-use assets	104.4	84.4
Goodwill	1,605.3	1,145.1
Other intangible assets, net	956.1	399.4
Deferred income taxes	888.4	749.4
Other assets (Note 2)	683.5	463.2
Non-current assets of discontinued operations (Note 5)	10.5	311.1
Total assets	12,971.2	9,363.2
Current liabilities
Accounts payable	172.8	186.6
Accrued and other liabilities (Note 2)	1,745.3	856.4
Operating lease liabilities	24.2	22.9
Current liabilities of discontinued operations (Note 5)	1.8	129.5
Total current liabilities	1,944.1	1,195.4
Long-term debt	597.5	597.0
Taxes payable	1.1	80.6
Operating lease liabilities	85.0	65.2
Uncertain tax positions	345.6	335.0
Litigation settlement accrual	63.9	94.2
Other liabilities	322.6	251.3
Non-current liabilities of discontinued operations (Note 5)	0.0	25.1
Total liabilities	3,359.8	2,643.8
Commitments and contingencies (Note 13)
Stockholders' equity
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding	0.0	0.0
Common stock, $1.00 par value, 1,050.0 shares authorized, 654.3 and 650.5 shares issued, and 589.8 and 601.1 shares outstanding, respectively	654.3	650.5
Additional paid-in capital	2,452.1	2,274.4
Retained earnings	12,781.4	8,992.4
Accumulated other comprehensive loss (Note 14)	(252.5)	(242.8)
Treasury stock, at cost, 64.5 and 49.4 shares, respectively	(6,089.7)	(5,024.5)
Total Edwards Lifesciences Corporation stockholders' equity	9,545.6	6,650.0
Noncontrolling interest	65.8	69.4
Total stockholders' equity	9,611.4	6,719.4
Total liabilities and equity	$ 12,971.2	$ 9,363.2

Accrued And Other Liabilities, Current

No definition available.

Name:	ew_AccruedAndOtherLiabilitiesCurrent
Namespace Prefix:	ew_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).